Table 1 Treatment regimens for MDR-TB patients in Yemen

RHSE

Regimen 1

8 months of amikacin + levofloxacin + ethionamide + cycloserine + para-aminosalicylic acid, followed by

16 months of levofloxacin + ethionamide + cycloserine + para-aminosalicylic acid

RHS

Regimen 2

8 months of amikacin + levofloxacin + ethionamide + cycloserine + pyrazinamide, followed by

16 months of levofloxacin + ethionamide + cycloserine + pyrazinamide

RH

Regimen 3

8 months of amikacin + levofloxacin + ethionamide + cycloserine + ethambutol, followed by

16 months of levofloxacin + ethionamide + cycloserine + ethambutol